The Pfizer COVID-19 vaccine causes allergic reactions at a higher rate than “what one would expect from” other blows, says Chief Scientific Adviser for Operation Warp Speed
- Dr. Moncef Slaoui said the last time he was updated on allergic reactions was on Tuesday, when there were six cases.
- “This frequency, as it was yesterday, is higher than what could be expected with other vaccines,” he said.
- There are discussions between vaccine manufacturers and the National Institutes of Health to consider conducting clinical trials of vaccines in highly allergic groups.
- The potential study could look at vaccines given by Pfizer and Moderna, although the reactions were only reported by people who were shot by Pfizer.
Chief Scientific Adviser for Operation Warp Speed said on Wednesday that the COVID-19 Pfizer vaccine causes more allergic reactions than is commonly seen in other vaccines.
Dr. Moncef Slaoui said the last time he was updated on allergic reactions was on Tuesday, when there were six cases, CNN reported.
“This frequency, as it was yesterday, is higher than what could be expected with other vaccines,” he said.
Dr. Moncef Slaoui said the last time he was updated on allergic reactions was on Tuesday, when there were six cases of allergic reactions.
Dr. Slaoui noted that data on coronavirus immunizations remain behind the actual number.
He added that there are discussions between vaccine manufacturers and the National Institutes of Health to consider conducting clinical trials of vaccines in highly allergic populations, ideally those who carry an EpiPen with them.
Carrying out the process could help to understand what causes allergic reactions, said Dr. Slaoui.
On Monday, an official from the National Institute of Allergy and Infectious Diseases told CNBC that the United States is analyzing the reasons why people suffered severe allergic reactions after receiving the COVID-19 vaccine.
There are discussions between vaccine manufacturers and the National Institutes of Health to consider conducting clinical trials of vaccines in highly allergic groups.
A study is currently in the early stages of planning and is expected to include “several hundred” people with a history of severe allergic reactions, according to Alkis Togias, head of NIAID’s allergy, asthma and respiratory biology branch.
His department will lead the study, which we hope will begin in the coming weeks.
The study could look at vaccines given by Pfizer and Moderna, although the reactions were only reported by people who were shot by Pfizer.
A New York medical worker has become the sixth known person to suffer a “severe” allergic reaction to a COVID-19 vaccine.
Two British health workers went into anaphylactic shock when they received him in the first week after his release, and three from Alaska suffered similar reactions.
More than 30,000 COVID-19 vaccines have been given in New York and are the only known people who have had a reaction.